News

Telehealth and technology have broadened the capabilities of surgeons.

Tafamidis and tafamidis meglumine reported a greater survival rate in treated patients than those administered placebo, and reported a reduced rate of hospitalizations from cardiovascular problems.

Esketamine nasal spray is currently relegated to a specific depression patient population, but that may not be for long.

Research has shown that few children with asthma correctly use their inhalers, despite guidelines explicitly stating that each physician visit should include review of inhaler technique and use of devices.

In a study that builds upon the hypothesis, researchers say early-in-life health factors can have an impact on adults’ health.

The SmartSync includes a mobile application, telemetry head, and pacing system analyzer that allows for direct patient-to-physician data sharing.

The GSK triple-combination FF/UMEC/VI inhaler reported significant lung function improvement in patients with inadequately controlled asthma.

A new meta analysis speculates whether specialists or primary care physicians are the best clinicians to diagnose, treat, and manage COPD.

The tropical-based virus is prevalent in areas inhabited by about one-third of the world's population.

How wearable devices and their massive patient pools have created a balancing act between mass patient arrhythmia data collection and individualized care.

Marketed sunscreen in the US is a bit more regulated than in other countries. But are those regulations helpful?

A major clinical challenge encountered by thoracic surgeons lies in the decision to pursue surgery, which must be weighed between surgical risk and the reliability of CT findings.

Some programs are governed by medical or radiation oncology departments, whereas others are led by pulmonology, radiology, pathology, or thoracic surgery departments, often in multidisciplinary combinations.

Most programs offer smoking cessation counseling as part of the shared decision making visit and throughout the program. Some LCS programs also order pulmonary function studies for new patients to provide an overall picture of lung health.

Patient management software programs have been developed to help track patients in LCS programs. These programs can automatically generate reminders for patients in the form of letters and phone calls.

To confirm that LCS programs abide by the American College of Radiology and Society of Thoracic Radiology specifications, screening should follow a standardized and structured protocol.

Most LCS programs have systems in place to ensure compliance with the eligibility criteria before an exam is scheduled and a scan is performed.

Regardless of the type of program structure, most experts agree that a program coordinator is critical for developing a successful program.

Hybrid lung cancer screening programs use a combination of centralized and decentralized services.

LCS programs must be integrated with a smoking cessation program, and data should be collected regarding the interventions offered to active smokers.

In a 47-patient study, all who received the therapy for either 8 or 16 weeks had no detected virus in their blood samples post-12 weeks, indicating cured infection.

Measles cases in the US have reached 700 this year, but the true threat is those who willingly exempt their children from the vaccination.

From 2010 to 2017, there was an increase of over 30% in the number of commercially insured children being diagnosed with ADHD.

A new NIH-funded study showed that patients with atopic dermatitis may increase their risk of food allergies when they scratch their skin.

Recent findings show that borderline deficiency is prevalent in about half of all stroke patients. Are vitamin B1 levels being tested enough, and are deficiencies affecting stroke rehabilitation?

How does a cardiologist balance the benefits of invasive care with the patients' interest in non-invasive measures?

Data from ACC 2018 showed the PCSK9 inhibitor is associated with an absolute risk reduction of 1.6% in treated patients versus placebo.

A new study from Canada found children as young as 9 months of age can safely undergo the desensitization treatment routinely.